Internist HematologistErasmus MCRotterdam Zuid Holland, Zuid-Holland, Netherlands
OC 13.3 - Pooled Analysis of the Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients With Previously Treated Immune Thrombocytopenia: Phase 2 Study
Sunday, June 23, 202410:00 – 10:15 ICT
OC 34.4 - Association of NETS and inflammation biomarkers with clinical outcome in patients with acute ischemic stroke undergoing thrombectomy: does heparin treatment modify this?
Monday, June 24, 202410:15 – 10:30 ICT
